[前列腺癌放射治疗后剂量与解剖结构和勃起功能障碍之间的关系:系统综述]
概括
前列腺辐射后的勃起功能障碍是复杂的. 目前的数据显示,阴茎结构的辐射剂量与勃起功能障碍之间的相关性有限,需要进一步研究.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 辐射瘤学 辐射瘤学
- 性医学性医学性医学性医学
背景情况:
- 前列腺放射治疗可以通过破坏周围的解剖结构来引起勃起功能障碍.
- 面临风险的结构包括洞穴体,内动脉,阴茎球体和神经血管捆.
- 现有的研究探讨了辐射和勃起功能之间的剂量反应关系.
研究的目的:
- 系统地审查当前关于辐射剂量与特定解剖结构之间的相关性和前列腺放射治疗后勃起功能障碍的知识.
主要方法:
- 使用PubMed进行了一项系统的文献审查,寻找与勃起功能障碍与阴茎结构辐射剂量相关的文章.
- 关键词包括"勃起功能障碍"",阴茎球体"", corpora cavernosa"",神经血管捆绑"和"放射治疗".
- 从最初的152个确定中,有45篇文章符合选择标准.
主要成果:
- 对于 corpora cavernosa (2/7研究) 和阴茎球 (15/23研究) 的辐射剂量和勃起功能障碍之间发现了有限的显著相关性.
- 平均阴茎球球剂量>20Gy是勃起功能障碍的预测.
- 对于神经血管捆绑 (0/8项研究) 没有发现相关性,而一项研究也没有发现内部尾动脉的相关性.
结论:
- 目前的证据提供了关于辐射剂量与性结构和勃起功能障碍之间的直接相关性的有限数据.
- 需要进行前性研究,以评估优化这些结构的辐射输送对勃起功能保护的影响.
相关概念视频
01:20Disorders of the Male Reproductive System
457
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
457
01:22Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
01:03Dose-Response Relationship: Overview
3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
02:59Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
01:11Renal Failure: Dose Adjustments
121
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
121
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
187
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
187